level-one heading

Kolabtreeを選ぶ理由
開始はすばやく簡単です。初期費用はかかりません。
サービス依頼と専門家への見積依頼は無料です。
Kolabtree の作業範囲に同意する前に、専門家と要件を詳しく相談できます。
専門家と直接連携し、必要な成果を正しく得られます。
専門家を採用したらプロジェクトに資金を入れ、作業完了後に成果物を承認できます。
この専門家をプロジェクトに採用したいですか? 見積もりを依頼 無料で。
プロフィール詳細
プロジェクトを作成
★★★★★
☆☆☆☆☆
Dr. Riley C.に依頼
United States

Neuroscience PhD and science communicator helping researchers turn their science into stories.

プロフィール概要
専門分野
サービス
Writing Medical Writing, Technical Writing, Copywriting, General Proofreading & Editing
職務経験

Grant Specialist

Will of Iron Foundation

12月 2024 - 現在

Freelance medical writer and editor

Riley Catenacci Medical Communications

12月 2024 - 現在

Graduate Student (Ph.D.)

Johns Hopkins University School of Medicine

9月 2019 - 8月 2024

Editor-in-Chief

JHU ReVision

4月 2020 - 1月 2024

Blog Content Writer

Sparrow Science

9月 2022 - 10月 2023

Research Technician

Washington University in St. Louis

7月 2018 - 12月 2018

Undergraduate Research Assistant

Massachusetts General Hospital

7月 2017 - 4月 2018

学歴

PhD, Neuroscience

Johns Hopkins University

8月 2019 - 8月 2024

BS, Behavioral Neuroscience

Northeastern University

9月 2015 - 5月 2019

認定資格
出版物
JOURNAL ARTICLE
Larissa Jank, Riley B. Catenacci, Veronica Minney, Danny Galleguillos, Peter A. Calabresi (2024). Pharmacological modulation of inflammatory oligodendrocyte progenitor cells using three multiple sclerosis disease modifying therapies in vitro . Neurotherapeutics.
Cole A Harrington, Riley B Catenacci, Matthew D Smith, Dongeun Heo, Cecilia Miller, Keya R Meyers, Jenna Glatzer, Dwight Bergles, Peter A Calabresi (2023). MHC class I and MHC class II reporter mice enable analysis of immune oligodendroglia in mouse models of multiple sclerosis . eLife.
Marjan Gharagozloo, Riley Bannon, Peter A. Calabresi (2022). Breaking the barriers to remyelination in multiple sclerosis . Current Opinion in Pharmacology.
Simon Dujardin, Analiese R. Fernandes, Riley Bannon, Caitlin Commins, Mark De Los Santos, Tarun V. Kamath, Mansuo Hayashi, Bradley T. Hyman (2022). Tau propagation is dependent on the genetic background of mouse strains . Brain Communications.
Kathleen Schoch, Lubov Ezerskiy, Michaela M. Morhaus, Riley N. Bannon, Andrew D. Sauerbeck, Mark Shabsovich, Paymaan Jafar-nejad, Frank Rigo, Timothy Miller (2021). Acute Trem2 reduction triggers increased microglial phagocytosis, slowing amyloid deposition in mice . Proceedings of the National Academy of Sciences.
Marjan Gharagozloo, Matthew D. Smith, Elias S. Sotirchos, Jing Jin, Keya Meyers, Michelle Taylor, Thomas Garton, Riley Bannon, Hannah-Noelle Lord, Ted M. Dawson, et al. (2021). Therapeutic Potential of a Novel Glucagon-like Peptide-1 Receptor Agonist, NLY01, in Experimental Autoimmune Encephalomyelitis . Neurotherapeutics.
Susanne Wegmann, Sarah DeVos, bryan zeitler, Kim Marlen, Rachel Bennett, Marta Perez-Rando, Danny MacKenzie Jr, Qi Yu, Caitlin Commins, Riley N. Bannon, et al. (2021). Persistent repression of tau in the brain using engineered zinc finger protein transcription factors . Science Advances.
Sarah L DeVos, Bianca T Corjuc, Caitlin Commins, Simon Dujardin, Riley N Bannon, Diana Corjuc, Benjamin D Moore, Rachel E Bennett, Mehdi Jorfi, Jose A Gonzales, et al. (2018). Tau reduction in the presence of amyloid-β prevents tau pathology and neuronal death in vivo . Brain.
Sarah L. DeVos, Bianca T. Corjuc, Derek H. Oakley, Chloe K. Nobuhara, Riley N. Bannon, Alison Chase, Caitlin Commins, Jose A. Gonzalez, Patrick M. Dooley, Matthew P. Frosch, et al. (2018). Synaptic Tau Seeding Precedes Tau Pathology in Human Alzheimer's Disease Brain . Frontiers in Neuroscience.